SuperworthClover Health Investments EPS CLOV
Diluted earnings per share by quarter and over the last twelve months, from 2020.
- Last 12 months, to Jun 30, 2026
- −$0.05
- Latest quarter, Q2 FY26
- $0.05
- Fiscal year 2025
- −$0.17
Clover Health Investments' earnings per share was −$0.05 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was $0.05.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$0.17 | n/a |
| FY2024 | −$0.10 | n/a |
| FY2023 | −$0.45 | n/a |
| FY2022 | −$0.72 | n/a |
| FY2021 | −$1.44 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.05 | n/a | −$0.05 | |
| Q1 FY26 | $0.05 | n/a | −$0.12 | |
| Q4 FY25 | −$0.10 | n/a | −$0.17 | |
| Q3 FY25 | −$0.05 | n/a | −$0.11 | |
| Q2 FY25 | −$0.02 | −300% | −$0.08 | |
| Q1 FY25 | $0.00 | n/a | −$0.05 | |
| Q4 FY24 | −$0.04 | n/a | −$0.10 | |
| Q3 FY24 | −$0.02 | n/a | −$0.21 | |
| Q2 FY24 | $0.01 | n/a | −$0.26 | |
| Q1 FY24 | −$0.05 | n/a | −$0.33 | |
| Q4 FY23 | −$0.15 | n/a | −$0.45 | |
| Q3 FY23 | −$0.07 | n/a | −$0.48 |
Against its peers
Companies in Medical - Healthcare Plans nearest Clover Health Investments' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| CLOVClover Health Investments | −$0.05 | |
| ALHCAlignment Healthcare | $0.19 | |
| TRUPTrupanion | $0.53 | +104% a year |
| OSCROscar Health | $1.39 | |
| Peer median | $0.53 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Clover Health Investments
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.